REFERENCES
- Jabs DA, Martin BK, Forman MS, et al. Mutations confer-ring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovi-rus retinitis. J Infect Dis. 2001183(2):333–337.
- Chou S, Lurain NS, Weinberg A, Cai GY, Sharma PL, Crumpacker CS. Interstrain variation in the human cyto-megalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother 1999;43(6)1 500–1502.
- Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev. 2006;8(2):88–97.
- Nies-Kraske E, Schacker TW, Condoluci D, et al. Evalu-ation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. J Infect Dis. 2009;199(11):1648–1656.
- Miller DM, Cebulla CM, Sedmak DD. Human cytomega-lovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. Curr Top Microbiol Immunol. 2002;269:153–170.
- Rodriguez JE, Loepfe TR, Stinski MF. Human cytomegalo-virus persists in cells treated with interferon. Brief report. Arch Virol. 1983;77(2-4):277–281.
- Grundy JE, Trapman J, Allan JE, Shellam GR, Melief CJ. Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun. 1982;37(1)1 43–150.